Document Page: First | Prev | Next | All | Image | This Release | Search

File: 970107_sep96_decls4_0003.txt
Page: 0003
Total Pages: 6

Subject: PREVENTIVE MEDICINE INFO UPDATED DISRAP  23 AUG 90              

Unit: VAR. BUMED  

Parent Organization: BUMED       

Box  ID: BX303902

Folder Title: CONVULSION ANTIDOTE FOR NERVE AGENT EXPOSURE                                                    

Document Number:          2

Folder Seq  #:          1



                                                                           14ql 27(o'O

                                       UNCLASSIFIED


        S-OUTHMESTERN SAUDI ARABIAT IN THE MOST SOUTHERN AREAS IN JIZAN
        .PRDVINCE, TRANSMISSION OCCURS $D!ITH OF 18 DEGREES NORTH LATITUDE
        (SOUTH OF THE TD@NS OF ADHA AND XHAMIS MUSHAYTP ORIC)I ARE LOCATED
        ABOUT $00 KILOMETERS SOUTH OF JEDnAI4)* NO DRUG RES18TANI FORMS
        REPORTEnt ALTHOUGH SOME CHLORnOUlhIE RESISTANCE IS SUSPECTED. PEAK
        RISK IS NOV-@iAR.    CHEMOPROPHYLAXTS WITH CHLOROGURNE AND TERMINAL
        PROPHYLAXIS WITH CHLOROQUINE/PRlf4AQIJINE ARE RECOMMENDED ONLY FOR
        PER30NNEL VISITING RISK AREAS IN THE SOUTHERN JIZAN PRUVINCE*
        NOTE: PRIMAQURNE SHOULD NOT BE GIVEN To PERSONS KNOON TO BE G6PD



        PAGE 06 RUFRSGG9748 UNCLAS
        DEFFICIENT, INDIVIDUALS WHO DO NOT RECEIVE PRIMAQUINE SHOULD BE
        COUNSELLED THAT THEY MAY EXPERIENCE A DELAYED CASE OF RELAPSING
        (VIVAX DR OVALE) FAALARIA WEEKS TO YE-AR$ AFTER EXPOSURE#      ALL FEBRILE
        EPISODES SHOULD OS REPORTED TO A PHYSICrANt WHO SHOULD BE MADE AWARE
        OF THE POSSIBILITY OF MALARIA, IN GENERALT RELAPSING MALARIA 13
        EASILY TREATED AND NOT LIFE-THREATENING, PERSONAL. PROTECTIVE
        MEASURES (SUCH AS PROPER CLOTHINGT DEETO AND BED NET$) SHOULD ALWAYS
        BE STRESSED.    MEDICAL DEPARTMENT PERSONNEL SHOULD RF.VIEA THE
        LASNRATORY ANI) CLINICAL DIAGNOSIS OF MALARIAT As WELL AS TREATMENT,
        AN ADEQUATE SUPPLY OF TREATMENT DRUGS SIICI4 AS FA-'43IDAR* QUININE?
        AND/OR @ALFLOQUINE SHOULD BE READILY AVAILABLE. A RECOMMENDED
        REFERENCE IS THE NAVY MEDICAL DEPARTMENT GUIDE TO 14ALARIA PREVEJYTIUN
        AND CONTROL. NO CHEMOPROPHYLAXTS IS RECOMMENDED FOR TRANSIT OF THE
        RED SFAR WITHOUT A PORT VISITP SINCE VESSELS IN TRANSIT ARE NOT
        CONSIDEPED At RISK.
        7.    OTHER VECTOR BORNE DISEASES# LOW RT$KO DISEASES REPORTED TU
13HIIIANTASIS (APFIROX,
        2,6 CASFS PER IOPOOO POP*)# FILARTASISR ONCHOCERCIASISP VIRAL
        ENCEPRALrTist SANDFLY FEVER# TICK STIRNE RELAPSING FEVER, TYPHUS AND
        DENCUE* CUTANEOUS LE13MMANIASIS TS ENDEMIC ALONG THE BORDER WITH
        ST
        #9748 NtiNti

























                                        UNCLASSIFIED

Document Page: First | Prev | Next | All | Image | This Release | Search


Document 6 f:/Week-44/BX303902/CONVULSION ANTIDOTE FOR NERVE AGENT EXPOSURE/preventive medicine info updated disrap 23 aug :0102970936115
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-44
Box ID = BX303902
Unit = VAR. BUMED
Parent Organization = BUMED
Folder Title = CONVULSION ANTIDOTE FOR NERVE AGENT EXPOSURE
Folder Seq # = 1
Subject = PREVENTIVE MEDICINE INFO UPDATED DISRAP 23 AUG
Document Seq # = 2
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 02-JAN-1997